Monthly Archives: July 2016

Myths Pertaining to Fabletics and How Kate Hudson Abolishes Them

Most of the time, people believe that they truly know it all, but what if they were told that they can know a lot about a subject and still only be brushing its surface? For example, people understand that Fabletics is a clothing line that has Kate Hudson as a spokeswoman, is composed of athletic wear, and can be worn… Read more »

Doe Deere Rewrites The Rules On Female Entrepreneurship

Women who want to start a business today face all kinds of obstacles. Starting a business requires many skills of all kinds as well as grit, determination and the ability to work with people from all walks of life and all backgrounds. This is something that entrepreneur Doe Deere knows all too well. As she tells Galore Magazine, it is… Read more »

Top Hair Hacks

FB   July 11, 2016   No Comments on Top Hair Hacks

When it comes to the hair, Wengie has a few hacks that every girl should know about. They will make the hair softer, shinier and a little more manageable whether you’re at home or traveling. Healthy hair starts on the inside. Vitamin C, A and omega-3 fatty acids are what you need to consume when you’re eating so that the… Read more »

Doe Deere and the Beauty Revolution

  Whoever said that “natural beauty” was important had clearly never met Doe Deere. Born in Russia and raised in New York, Deere is the founder of Lime Crime Cosmetics and has revolutionized the beauty industry with her new take on bold and artistic looks. While her success is undeniable, how exactly was the idea for Lime Crime conceived? Birth… Read more »

Dr. Siegall and Mirna

Dr. Siegall, as of January 30th, 2013 was accepted as an outside director of the distinguished Mirna team. Dr. Siegall co-founded Seattle Genetics in 1998, and under his experience and guidance, the company built a distinct antibody-based therapy that addressed unmet needs of patients suffering from cancer. Furthermore Dr. Siegall secured more than $675 million through both public and private funding sources. The treatment of cancer has expanded into uncharted territories over the last few years. Dr. Siegall has achieved a paramount position in many of the new and exciting research modalities and implementation of these findings in today’s cancer treatment. While no treatment offers a guaranteed in curative effectives or even alleviating effectives, Dr. Siegall’s research show insurmountable promise. Recently, in a keynote address, Dr. Siegall expressed optimism in two current proposed treatment regimes to include: SGN-CD33A and SGN-CD19A. SGN-CD33A is to target acute myeloid leukemia cells, whereas SGN-CD19A is stable in the bloodstream, and is to release its cytotoxic agent upon internalization into CD19-expressing tumor cells, sparing the body of many of the toxic effects of traditional chemotherapy. These techniques, where as may not be familiar to the general public, may in fact lie the key to the future of cancer treatment, and may ultimately affect the curative rates of certain cancers. Regardless of the actual outcome these studies introduced by Dr. Siegall and invested by numerous public and private entities, cancer research and cancer treatments are evolving. Today’s technology and advancements in understanding of cellular structure and reproduction of not only healthy cells, but destructive cells as well lead us closer to cancer cures everyday.